|
🐜
|
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
106 auth.
Vincent C. Marconi,
A. Ramanan,
S. de Bono,
Cynthia E. Kartman,
V. Krishnan,
R. Liao,
M. L. B. Piruzeli,
Jason D. Goldman,
Jorge Alatorre-Alexander,
Rita de Cassia Pellegrini,
Vicente Estrada,
Mousumi Som,
A. Cardoso,
Sujatro Chakladar,
Brenda J. Crowe,
...
P. Reis,
X. Zhang,
D. Adams,
E. W. Ely,
M. Ahn,
M. Akasbi,
Jorge Alatorre-Alexander,
J. Altclas,
F. Ariel,
H. Ariza,
C. Atkar,
A. Bertetti,
M. Bhattacharya,
M. L. Briones,
A. Budhraja,
A. Burza,
Adrian Camacho Ortiz,
R. Caricchio,
M. Casas,
Valeria Cevoli Recio,
W. Choi,
Emilia Cohen,
Angel Comulada-Rivera,
Paul Cook,
Dora Patricia Cornejo Juarez,
Carnevali Daniel,
Luiz Fernando Degrecci Relvas,
Jose Guillermo Dominguez Cherit,
T. Ellerin,
D. Enikeev,
Suzana Erico Tanni Minamoto,
Vicente Estrada,
E. Fiss,
M. Furuichi,
Kleber Giovanni Luz,
Jason D. Goldman,
O. González,
I. Gordeev,
T. Gruenewald,
Victor Augusto Hamamoto Sato,
Eun Young Heo,
J. Heo,
M. Hermida,
Yuji Hirai,
D. Hutchinson,
Claudio Iastrebner,
O. Ioachimescu,
Manish Jain,
Maria Patelli Juliani Souza Lima,
Akram Khan,
A. Kremer,
T. Lawrie,
Mark Macelwee,
F. Madhani-Lovely,
V. Malhotra,
M. F. Martínez Resendez,
James McKinnell,
P. Milligan,
C. Minelli,
Miguel Ángel Morán Rodríguez,
M. L. Parody,
P. Paulin,
R. Pellegrini,
Priscilla Pemu,
Ana Carolina Procopio Carvalho,
M. Puoti,
J. Purow,
M. Ramesh,
Álvaro Réa Neto,
Philip G. Robinson,
Cristhieni Rodrigues,
Gustavo Rojas Velasco,
J. Saraiva,
M. Scheinberg,
S. Schreiber,
D. Scublinsky,
A. Sevciovic Grumach,
Imad Shawa,
J. S. Simón Campos,
N. Sofat,
Mousumi Som,
C. Spinner,
E. Sprinz,
R. Stienecker,
J. Suárez,
N. Tachikawa,
H. Tahir,
B. Tiffany,
A. Vishnevsky,
Adilson Westheimer Cavalcante,
K. Zirpe
|
8 |
2021 |
8
🐜
|
